Bluesky Facebook Reddit Email

Lin studying gene transcription in blood of patients treated for opioid use disorder

03.20.20 | George Mason University

Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

MingKuan Lin, Research Assistant Professor, INOVA Neuroscience, School of Systems Biology, is working to measure gene expression levels in blood from patients undergoing treatment with buprenorphine for opioid use disorder.

Transcription is the process in which a segment of DNA is transcripted into RNA by the enzyme RNA polymerase.

As part of this project, Lin is completing two tasks.

First, he is performing bioinformatics analysis of differential gene expression, including data import, preprocessing, differential expression analysis and enrichment analysis.

Second, he is performing statistical analysis for the association of differential gene expression and clinical results.

Lin received $34,122 from Inova Healthcare for this research. Funding began in January 2020 and will conclude in early July 2020.

###

Keywords

Contact Information

Elizabeth Grisham
egrisham@gmu.edu

How to Cite This Article

APA:
George Mason University. (2020, March 20). Lin studying gene transcription in blood of patients treated for opioid use disorder. Brightsurf News. https://www.brightsurf.com/news/LVDZQ05L/lin-studying-gene-transcription-in-blood-of-patients-treated-for-opioid-use-disorder.html
MLA:
"Lin studying gene transcription in blood of patients treated for opioid use disorder." Brightsurf News, Mar. 20 2020, https://www.brightsurf.com/news/LVDZQ05L/lin-studying-gene-transcription-in-blood-of-patients-treated-for-opioid-use-disorder.html.